Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Med-tech titan Covidien (NYSE:COV) agreed to acquire Sunnyvale, Calif.-based device maker Barrx Medical Inc. for $325 million in a deal slated to close by January 31, 2012.
Former Synthes Inc. North America president Michael Huggins and former executive VP Thomas Higgins were both sentenced to 9 months in federal prison for roles in unauthorized Norian bone cement trials in which three patients died during surgery.
A study of St. Jude Medical’s (NYSE:STJ) Libra found that the deep brain stimulation implant proved safe and effective in treatment of patients with severe therapy-resistant depression.